Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection

JAMA

2023-10-14

(Press-News.org) About The Study: Among 2,511 adults hospitalized with acute infection, treatment with the antibiotic piperacillin-tazobactam did not increase the incidence of acute kidney injury or death in this randomized clinical trial. Treatment with the antibiotic cefepime resulted in more neurological dysfunction.

Authors: Edward T. Qian, M.D., M.Sc., of Vanderbilt University Medical Center in Nashville, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.20583)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being released to coincide with presentation at IDWeek 2023.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20583?guestAccessKey=b6319680-f2a7-465d-8780-308833742dea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101423

END

ELSE PRESS RELEASES FROM THIS DATE:

Virtual reality reduces anxiety among caregivers of children having surgery, study finds

2023-10-14

SAN FRANCISCO — Virtual reality (VR) may be an effective and reliable tool to alleviate the anxiety experienced by most parents or caregivers when their child undergoes surgery, according to research presented at the ANESTHESIOLOGY® 2023 annual meeting. “When a child has a medical procedure, it is often emotionally unsettling for not just the patient, but the entire family,” said Thomas J. Caruso, M.D., Ph.D., FASA, senior author of the study and clinical professor of anesthesiology, perioperative and pain medicine at Stanford University, California. “By ...

American Society of Anesthesiologists honors Stanley W. Stead, M.D., MBA, FASA, with its Distinguished Service Award

2023-10-14

SAN FRANCISCO — The American Society of Anesthesiologists (ASA) today presented Stanley W. Stead, M.D., MBA, FASA, with its 2022 Distinguished Service Award in recognition of his enduring contributions to advancing patient-centered, physician-led health care, and his advocacy related to health care economics, including value-based care and equitable physician payment models. The award is the highest honor ASA bestows and is presented annually to a member who has transformed the specialty of anesthesiology. A nationally recognized thought leader in health care economics, information technology and quality of care, Dr. Stead ...

Move over carbon, the nanotube family just got bigger

2023-10-14

Tokyo, Japan – Researchers from Tokyo Metropolitan University have engineered a range of new single-walled transition metal dichalcogenide (TMD) nanotubes with different compositions, chirality, and diameters by templating off boron-nitride nanotubes. They also realized ultra-thin nanotubes grown inside the template, and successfully tailored compositions to create a family of new nanotubes. The ability to synthesize a diverse range of structures offers unique insights into their growth mechanism ...

RESEARCH ALERT: City of Hope researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

2023-10-14

FINDINGS In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and other institutions found that nongenetic mechanisms are important in lung cancer patients who develop a resistance to one cancer therapy. Their findings were published in the October 13 issue of the journal Science Advances. The team’s study explored resistance to the anti-cancer medication sotorasib in patients with non-small cell lung cancer (NSCLC). Sotorasib inhibits a specific mutation ...

A new classification of heart rhythm for stroke patients

2023-10-14

London, Ont.,: Worldwide, millions of stroke survivors undergo prolonged cardiac monitoring, leading to the discovery of atrial fibrillation, or irregular heartbeats, in up to 1.5 million of these patients each year. A new study, published in The Lancet Neurology, describes the knowledge on atrial fibrillation detected in patients who had a recent stroke. The publication suggests that atrial fibrillation detected post-stroke is not quite the same as the irregular heartbeats already known before a stroke. The study, led by Western University professor Dr. Luciano Sposato, proposes that atrial fibrillation detected post-stroke exhibits distinct ...

Losing weight as a couple? It’s just as good to go it alone

2023-10-13

New research has underscored how characteristics of “grit” and self-control are associated with better weight loss and weight maintenance outcomes in a study focusing on couples. And that these characteristics can change through behavioral interventions. This research led by Amy Gorin, professor of psychological sciences and vice provost for health sciences and interdisciplinary initiatives; and Tricia Leahey, professor of allied health sciences in the College of Agriculture, Health and Natural ...

On top again: UTA wins national award for noise control engineering

2023-10-13

For the fourth time in five years, students at The University of Texas at Arlington have won a prestigious national award for noise control engineering. Ross Everett and Bret Johnson, mechanical engineering students who graduated in May 2023, earned the Leo Beranek Student Medal for Excellence in the Study of Noise Control from the Institute of Noise Control Engineering of the USA for their work to decrease cabin noise in the autonomous rideshare cars owned by May Mobility that operate around UTA’s campus. The institute awards the medal annually to outstanding undergraduate and graduate ...

For toddlers allergic to peanuts, a tiny bit of protein therapy under the tongue could be the best approach

2023-10-13

CHAPEL HILL, NC — A three-year clinical trial funded by the National Institutes of Health and Food Allergy Research and Education (FARE) has shown that the sublingual immunotherapy, or SLIT, is safe in peanut-allergic children ages 1 to 4, with a greater likelihood of desensitization and remission the earlier the treatment began. Led by Edwin Kim, MD, associate professor of pediatrics at the UNC School of Medicine, this is the first randomized, controlled trial to investigate – in this young age group – the efficacy and feasibility of SLIT, which ...

Study explores how changing autism traits are linked to mental health conditions

2023-10-13

A long-term study by UC Davis Health researchers sheds new light on the relationship between autism traits and mental health in middle childhood. The paper, published in the journal Autism, finds that changes in core autism characteristics are related to whether children develop additional mental health challenges during their elementary school years. “Our findings suggest that different aspects of a child’s development may affect each other over time,” explained Einat Waizbard-Bartov, a doctoral researcher in developmental psychology at the UC Davis MIND Institute and the lead author on the paper. “Core autism traits and ...

Dan M. Frangopol wins inaugural EuroStruct International Award of Merit

2023-10-13

Professor Dan M. Frangopol is the winner of the EuroStruct2023 International Award of Merit presented by the EuroStruct Executive Committee in recognition of outstanding contributions to bridge and structural asset management and structural engineering. Frangopol, the inaugural Fazlur R. Khan Endowed Chair of Structural Engineering and Architecture in the Department of Civil and Environmental Engineering at Lehigh, was presented with the award during EuroStruct 2023, the second Conference of the European ...

Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: